I also haven't had the stomach discomfort I used to have on Wegovy
However, the half-life of GLP-1 is too short at 1 to 2 minutes, making it difficult to use as a drug [21]
(2022) "Tirzepatide Once Weekly for the Treatment of Obesity" New England Journal of Medicine, 387(3) Average 15-21% weight loss* Tailored programmes built by real experts Targeted support to make success feel simpler Unique app with weight loss tools and lessons Your journey starts here Start your personalised weight loss plan in minutes
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD et al (2021) Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
The GLP-1 drug class includes Ozempic and Mounjaro, which are prescribed to treat diabetes, and Wegovy made by Novo Nordisk, which has been approved to treat weight loss
(2021) 2021:Cir0000000000000950